A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 116.47
GOOG 537.50
MSFT 47.98
FB 73.75
BAC 17.12

Recently Added

SPG 178.45
R 91.82
SKX 58.86
CTRE 15.57
BBRY 10.24

Gaining Speed

SPG 178.45
BABA 110.73
ETH 29.22
TMO 126.54
BA 132.78

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!